|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 101, 509-516, Copyright © 1991 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
J Wikman-Coffelt, S Wagner, S Wu and W Parmley
Isolated hamster hearts were first perfused with a normal Krebs- Henseleit
medium to demonstrate comparable viability of hearts before perfusing and
storing them for 24 hours in one of three solutions. The three solutions
were a physiologic saline with pyruvate as the substrate and 4% alcohol to
arrest the heart (group 1), a standard cardioplegic solution (group 2), and
an alcohol-free physiologic saline with pyruvate as the substrate (group
3). Recovery in terms of rate/pressure product and oxygen consumption after
30 minutes of reperfusion was 81% and 93%, respectively, for group 1, 13%
and 32% for group 2, and 70% and 72% for group 3. Percent of physiologic
recovery was not related to recovery of adenosine triphosphate. The
adenosine triphosphate level returned to approximately 40% control level in
all three groups, and in all three groups inorganic phosphate remained
approximately 320% over control level after 30 minutes of reperfusion.
Phosphocreatine level significantly higher in groups 1 and 3 than in group
2, as a result of improved oxygen consumption. Intracellular pH, determined
by phosphorous 31 nuclear magnetic resonance spectroscopy, was physiologic
in groups 1 and 3 but alkaline in group 2. This alkalinity may have been
caused by leaky membranes. Pyruvate helped preserve mitochondrial function
during depressed oxygen delivery, such as was seen during the 24-hour
storage period. Four percent alcohol arrested the heart; combined with
pyruvate plus alcohol solution were better than a standard cardioplegic
solution for maintaining functional capability.
ARTICLES
Alcohol and pyruvate cardioplegia. Twenty-four-hour in situ preservation of hamster hearts
Department of Medicine, University of California, San Francisco 94143.
This article has been cited by other articles:
![]() |
E. R. Rosenkranz Substrate Enhancement of Cardioplegic Solution: Experimental Studies and Clinical Evaluation Ann. Thorac. Surg., September 1, 1995; 60(3): 797 - 800. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |